ODDB.org: Open Drug Database | Medikamente

		Präparat	Zulassungsinhaber	Packungsgrösse	Zusammensetzung	PP	%	SB
FI	PI	Xatral uno	Sanofi-Aventis (Suisse) SA	30 Tablet(s)	Delayed release tablets: Alfuzosini Hydrochloridum 10 mg	32.65		10%
FI	PI	Alfuzosin Sandoz 10 mg	Sandoz Pharmaceuticals AG	90 Tablet(s)	Delayed release tablets: Alfuzosini Hydrochloridum 10 mg	55.55	-43%	10%
FI	PI	Alfuzosin axapharm	axapharm ag	90 Tablet(s)	Delayed release tablets: Alfuzosini Hydrochloridum 10 mg	55.55	-43%	10%
FI	PI	Xatral uno	Sanofi-Aventis (Suisse) SA	90 Tablet(s)	Delayed release tablets: Alfuzosini Hydrochloridum 10 mg	61.75	-36%	10%
FI	PI	Alfuzosin Sandoz 10 mg	Sandoz Pharmaceuticals AG	30 Tablet(s)	Delayed release tablets: Alfuzosini Hydrochloridum 10 mg	30.70	-5%	10%
FI	PI	Alfuzosin-Mepha retard	Mepha Pharma AG	30	Delayed release tablets: Alfuzosini Hydrochloridum 10 mg	30.70	-5%	10%
FI	PI	Alfuzosine Uno Zentiva 10 mg ‐ F	Helvepharm AG	30 Tablet(s)	Delayed release tablets: Alfuzosini Hydrochloridum 10 mg	30.70	-5%	10%
FI	PI	Alfuzosin axapharm	axapharm ag	30 Tablet(s)	Delayed release tablets: Alfuzosini Hydrochloridum 10 mg	30.75	-5%	10%
FI	PI	Alfuzosin Sandoz 10 mg	Sandoz Pharmaceuticals AG	10 Tablet(s)	Delayed release tablets: Alfuzosini Hydrochloridum 10 mg	14.25	+30%	10%
FI	PI	Alfuzosin axapharm	axapharm ag	10 Tablet(s)	Delayed release tablets: Alfuzosini Hydrochloridum 10 mg	14.35	+31%	10%
FI	PI	Xatral uno	Sanofi-Aventis (Suisse) SA	10 Tablet(s)	Delayed release tablets: Alfuzosini Hydrochloridum 10 mg	15.25	+40%	10%

Für den Direktvergleich klicken Sie bitte auf den Medikamentennamen im Suchergebnis!

Legende einblenden

2025	©ywesee GmbH